Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

Journal of the American Academy of Dermatology

Volumn 66, Issue 3, 2012, Pages 479-485

  Murrell, Dedee F ^a,d,h,k,o,ag   Daniel, Benjamin S ^a,d,h,k,o,ag   Joly, Pascal ^{a,b,d,h,k,o,ag}   Borradori, Luca ^{a,c,d,h,k,o,ag}   Amagai, Masayuki ^a,d,h,k,o,ag   Hashimoto, Takashi ^{a,d,e,h,k,o,ag}   Caux, Frédéric ^{a,d,f,h,k,o,ag}   Marinovic, Branka ^{a,d,g,h,k,o,ag}   Sinha, Animesh A ^a,d,h,k,o,ag   Hertl, Michael ^{a,d,h,i,k,o,ag}   Bernard, Philippe ^{a,d,h,k,o,ad,ag}   Sirois, David ^{a,d,h,j,k,o,ag}   Cianchini, Giuseppe ^a,d,h,k,o,ag   Fairley, Janet A ^{a,d,h,k,l,o,ag}   Jonkman, Marcel F ^{a,d,h,k,m,o,ag}   Pandya, Amit G ^{a,d,h,k,n,o,ag}   Rubenstein, David ^a,d,h,k,o,ag   Zillikens, Detlef ^{a,d,h,k,o,p,ag}   Payne, Aimee S ^{a,d,h,k,o,r,ag}   Woodley, David ^{a,d,h,k,o,q,ag}   Zambruno, Giovanna ^a,d,h,k,o,ag   Aoki, Valeria ^{a,d,h,k,o,s,ag}   Pincelli, Carlo ^{a,d,h,k,o,t,ag}   Diaz, Luis ^a,d,h,k,o,ag   Hall, Russell P ^{a,d,h,k,o,u,ag}   Meurer, Michael ^{a,d,h,k,o,w,ag}   Mascaro Jr , Jose M ^{a,d,h,k,o,x,ag}   Schmidt, Enno ^{a,d,h,k,o,p,ag}   Shimizu, Hiroshi ^{a,d,h,k,o,v,ag}   Zone, John ^{a,d,h,k,o,y,ag}   Swerlick, Robert ^{a,d,h,k,o,ab,ag}   Mimouni, Daniel ^{a,d,h,k,o,ac,ag}   Culton, Donna ^a,d,h,k,o,ag   Lipozencic, Jasna ^{a,d,g,h,k,o,ag}   Bince, Benjamin ^{a,d,h,k,o,z,ag}   Grando, Sergei A ^{a,d,h,k,o,ae,ag}   Bystryn, Jean Claude ^{a,d,h,k,o,aa,ag}   Werth, Victoria P ^{a,d,h,k,o,r,af,ag}   more..

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF BERN   (Switzerland)

^d KEIO UNIVERSITY   (Japan)

^e KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITÉ PARIS 13   (France)

^g UNIVERSITY OF ZAGREB   (Croatia)

^h UNIVERSITY AT BUFFALO   (United States)

ⁱ University Hospital   (United States)

^j NEW YORK UNIVERSITY   (United States)

^k LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^l UNIVERSITY OF IOWA   (United States)

^m UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁿ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^o UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF LÜBECK   (Germany)

^q UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s UNIVERSITY OF SÃO PAULO   (Brazil)

^t UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^u DUKE UNIVERSITY MEDICAL CENTER   (United States)

^v HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^w DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^x UNIVERSITY OF BARCELONA   (Spain)

^y UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^z Jose R Reyes Memorial Medical Center   (Philippines)

^aa NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^ab EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ac RABIN MEDICAL CENTER   (Israel)

^ad Department of Genetics   (France)

^ae UNIVERSITY OF CALIFORNIA   (United States)

^af DEPARTMENT OF VETERANS AFFAIRS   (United States)

^ag NONE

more..

Author keywords

bullous pemphigoid; consensus; definitions; outcome measures; severity score

Indexed keywords

AZATHIOPRINE; CLOBETASOL PROPIONATE; DAPSONE; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PREDNISONE; TETRACYCLINE;

BLISTER; BULLOUS PEMPHIGOID; DISEASE ACTIVITY; DISEASE CONTROL; ECZEMA; HUMAN; PRIORITY JOURNAL; PRURITUS; RELAPSE; REMISSION; REVIEW; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME; URTICARIA; VISUAL ANALOG SCALE;

CONSENSUS; DERMATOLOGY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PEMPHIGOID, BULLOUS; SEVERITY OF ILLNESS INDEX;

EID: 84857451523     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2011.06.032     Document Type: Review

References (10)

1. G. Kirtschig, P. Middleton, C. Bennett, D.F. Murrell, F. Wojnarowska, and N.P. Khumalo Interventions for bullous pemphigoid Cochrane Database Syst Rev 10 2010 CD002292
2. D.F. Murrell, S. Dick, A.R. Ahmed, M. Amagai, M.A. Barnadas, and L. Borradori Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus J Am Acad Dermatol 58 2008 1043 1046
3. M. Rosenbach, D.F. Murrell, J.C. Bystryn, S. Dulay, S. Dick, and S. Fakharzadeh Reliability and convergent validity of two outcome instruments for pemphigus J Invest Dermatol 129 2009 2404 2410
4. M. Pfutze, A. Niedermeier, M. Hertl, and R. Eming Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus Eur J Dermatol 17 2007 4 11 (Pubitemid 46383213)
5. D.F. Fiorentino, M.S. Garcia, W. Rehmus, and A.B. Kimball A pilot study of etanercept treatment for pemphigus vulgaris Arch Dermatol 147 2011 117 118
6. D.P. Fivenson, D.L. Breneman, G.B. Rosen, C.S. Hersh, S. Cardone, and D. Mutasim Nicotinamide and tetracycline therapy of bullous pemphigoid Arch Dermatol 130 1994 753 758 (Pubitemid 24182685)
7. P. Morel, and J.C. Guillaume Treatment of bullous pemphigoid with prednisolone only: 0.75 mg/kg/day versus 1.25 mg/kg/day; a multicenter randomized study Ann Dermatol Venereol 111 1984 925 928 (Pubitemid 15179493)
8. P. Joly, J.C. Roujeau, J. Benichou, C. Picard, B. Dreno, and E. Delaporte A comparison of oral and topical corticosteroids in patients with bullous pemphigoid N Engl J Med 346 2002 321 327 (Pubitemid 34438839)
9. P. Joly, J.C. Roujeau, J. Benichou, E. Delaporte, M. D'Incan, and B. Dreno A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study J Invest Dermatol 129 2009 1681 1687
10. P. Bernard, L. Vaillant, B. Labeille, C. Bedane, B. Arbeille, and J.P. Denoeux Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions; Bullous Diseases French Study Group Arch Dermatol 131 1995 48 52